NASDAQ NMS - GLOBAL MARKET · HOWL
-2.69% · -$0.0235 · Vol Not reported
Pre-market · updated 06:46:37 ET
Werewolf Therapeutics Inc

Werewolf Therapeutics Inc

Biotechnology
$0.8500
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
HOWL
Werewolf Therapeutics Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
BUY BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is HOWL moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading HOWL catalysts
About Werewolf Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
14
Country
US

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.8735
Last session
Day high
$0.8735
Last session
Day low
$0.8735
Last session
Previous close
$0.8735
52W high
$2.19
-61.19% from high
52W low
$0.3080
29% of range
Market cap
$21M
EPS
$-0.9600
Beta
2.45
Shares out
48.6M
Avg volume
12.6M
VWAP
$0.8735
Last session
Price history computed in-house
1W
+109.62%
1M
+99.06%
3M
+83.55%
1Y
-35.61%
YTD
+34.18%
SMA 50 $0.3892 · above
SMA 200 $0.6581 · above
52W position 29%

HOWL overview

Veridion Score
65
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around HOWL.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading HOWL Form 4 filings
Public disclosures

Congress activity in HOWL

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for HOWL in the cached public ledger.

Federal contracts

HOWL contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for HOWL in this window.
Lobbying spend

HOWL lobbying filings, year to date.

Registered lobbying filings matched to Werewolf Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for HOWL in this window.
Loading news for HOWL
Analyst ratings
Sovereign unlock shows live analyst consensus for HOWL.
Options
Sovereign unlock shows live options positioning for HOWL.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.